Annual CFF
$17.50 M
+$11.50 M+191.67%
December 31, 2023
Summary
- As of February 10, 2025, AGE annual cash flow from financing activities is $17.50 million, with the most recent change of +$11.50 million (+191.67%) on December 31, 2023.
- During the last 3 years, AGE annual CFF has risen by +$11.54 million (+193.57%).
Performance
AGE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$2.00 M
$0.000.00%
December 31, 2023
Summary
- As of February 10, 2025, AGE quarterly cash flow from financing activities is $2.00 million, unchanged on December 31, 2023.
- Over the past year, AGE quarterly CFF has increased by +$500.00 thousand (+33.33%).
Performance
AGE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$17.50 M
+$500.00 K+2.94%
December 31, 2023
Summary
- As of February 10, 2025, AGE TTM cash flow from financing activities is $17.50 million, with the most recent change of +$500.00 thousand (+2.94%) on December 31, 2023.
- Over the past year, AGE TTM CFF has increased by +$11.50 million (+191.67%).
Performance
AGE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AGE Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +191.7% | +33.3% | +191.7% |
| 3 y3 years | +193.6% | +101.6% | +193.6% |
| 5 y5 years | +191.7% | +100.0% | +179.3% |
AGE Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -65.7% | -82.6% | -50.0% | at high | -65.7% |
| 5 y | 5-year | at high | -65.9% | -82.6% | -90.8% | at high | -88.9% |
| alltime | all time | at high | -65.9% | -82.6% | -100.5% | at high | -95.8% |
AgeX Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $17.50 M(+191.7%) | $2.00 M(0.0%) | $17.50 M(+2.9%) |
| Sep 2023 | - | $2.00 M(0.0%) | $17.00 M(+6.3%) |
| Jun 2023 | - | $2.00 M(-82.6%) | $16.00 M(0.0%) |
| Mar 2023 | - | $11.50 M(+666.7%) | $16.00 M(+166.7%) |
| Dec 2022 | $6.00 M(-17.2%) | $1.50 M(+50.0%) | $6.00 M(0.0%) |
| Sep 2022 | - | $1.00 M(-50.0%) | $6.00 M(-14.3%) |
| Jun 2022 | - | $2.00 M(+33.3%) | $7.00 M(+7.7%) |
| Mar 2022 | - | $1.50 M(0.0%) | $6.50 M(-10.3%) |
| Dec 2021 | $7.25 M(+21.6%) | $1.50 M(-25.0%) | $7.25 M(+7.5%) |
| Sep 2021 | - | $2.00 M(+33.3%) | $6.74 M(+0.3%) |
| Jun 2021 | - | $1.50 M(-33.2%) | $6.71 M(-16.3%) |
| Mar 2021 | - | $2.25 M(+126.4%) | $8.02 M(+34.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $5.96 M(-4.9%) | $992.00 K(-49.8%) | $5.96 M(-4.7%) |
| Sep 2020 | - | $1.98 M(-29.6%) | $6.26 M(+31.3%) |
| Jun 2020 | - | $2.81 M(+1417.3%) | $4.77 M(+144.4%) |
| Mar 2020 | - | $185.00 K(-85.6%) | $1.95 M(-68.9%) |
| Dec 2019 | $6.26 M(+4.4%) | $1.29 M(+164.3%) | $6.26 M(+25.9%) |
| Sep 2019 | - | $487.00 K(-5511.1%) | $4.98 M(+4.7%) |
| Jun 2019 | - | -$9000.00(-100.2%) | $4.75 M(-51.3%) |
| Mar 2019 | - | $4.50 M(>+9900.0%) | $9.76 M(+62.7%) |
| Dec 2018 | $6.00 M(-54.8%) | $0.00(-100.0%) | $6.00 M(0.0%) |
| Sep 2018 | - | $263.00 K(-94.7%) | $6.00 M(+4.6%) |
| Jun 2018 | - | $5.00 M(+578.4%) | $5.74 M(+678.4%) |
| Mar 2018 | - | $737.00 K | $737.00 K |
| Dec 2017 | $13.28 M | - | - |
FAQ
- What is AgeX Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for AgeX Therapeutics?
- What is AgeX Therapeutics annual CFF year-on-year change?
- What is AgeX Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AgeX Therapeutics?
- What is AgeX Therapeutics quarterly CFF year-on-year change?
- What is AgeX Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for AgeX Therapeutics?
- What is AgeX Therapeutics TTM CFF year-on-year change?
What is AgeX Therapeutics annual cash flow from financing activities?
The current annual CFF of AGE is $17.50 M
What is the all time high annual CFF for AgeX Therapeutics?
AgeX Therapeutics all-time high annual cash flow from financing activities is $17.50 M
What is AgeX Therapeutics annual CFF year-on-year change?
Over the past year, AGE annual cash flow from financing activities has changed by +$11.50 M (+191.67%)
What is AgeX Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of AGE is $2.00 M
What is the all time high quarterly CFF for AgeX Therapeutics?
AgeX Therapeutics all-time high quarterly cash flow from financing activities is $11.50 M
What is AgeX Therapeutics quarterly CFF year-on-year change?
Over the past year, AGE quarterly cash flow from financing activities has changed by +$500.00 K (+33.33%)
What is AgeX Therapeutics TTM cash flow from financing activities?
The current TTM CFF of AGE is $17.50 M
What is the all time high TTM CFF for AgeX Therapeutics?
AgeX Therapeutics all-time high TTM cash flow from financing activities is $17.50 M
What is AgeX Therapeutics TTM CFF year-on-year change?
Over the past year, AGE TTM cash flow from financing activities has changed by +$11.50 M (+191.67%)